Selective COX-2 Inhibitors --- A Valuable Tool for COVID-19 Management
International Journal of Pharmacy and Chemistry · 21.01.2025 · 11 (1) · 11-15
DOI: 10.11648/j.ijpc.20251101.12 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pharmacy and Chemistry, online erschienen am 21.01.2025. Verfasst von Dairong Wang und 1 weiteren Autor:innen. Die Arbeit nennt 41 Literaturangaben.
Abstract (Originalsprache)
Cyclooxygenase 2 (COX-2) is highly induced during coronavirus (COVID-19) infection. We believe selective COX-2 inhibition shall be a valuable tool to reduce virus toxicity in related patients. Dexamethasone, one of potent selective COX-2 inhibitors, has been used successfully in the standard care for patients with COVID-19. Given that low-dose dexamethasone inhibits thrombosis, reduces the death rate by one-third in patients with severe COVID, and is in the same dose range for effective COX-2 inhibition, we believe that vascular COX-2 is coupled to thrombosis and it is critical to selectively inhibit COX-2 to avoid tissue damage and death in patients. We should take efforts to replace dexamethasone with non-steroidal selective COX-2 inhibitors such as celecoxib (Celebrex) and etoricoxib (Arcoxia) to avoid steroidal side effects. For detailed in vivo COX-2 analysis in the vasculature and other organs, we should leverage tools such as conditional knockout animal models to avoid cardiovascular congestion caused by renal COX-2 disruption. Detailed preclinic and clinic studies will help to develop selective COX-2 inhibition therapies for consistent applications across the population.
Zitieren
APA
Wang, D., & Tomera, K. (2025). Selective COX-2 Inhibitors --- A Valuable Tool for COVID-19 Management. International Journal of Pharmacy and Chemistry, 11(1), 11-15. https://doi.org/10.11648/j.ijpc.20251101.12
Vancouver
Wang D, Tomera K. Selective COX-2 Inhibitors --- A Valuable Tool for COVID-19 Management. International Journal of Pharmacy and Chemistry. 2025;11(1):11-15. doi:10.11648/j.ijpc.20251101.12
BibTeX
@article{Wang2025,
author = {Wang, Dairong and Tomera, Kevin},
title = {Selective COX-2 Inhibitors --- A Valuable Tool for COVID-19 Management},
journal = {International Journal of Pharmacy and Chemistry},
year = {2025},
volume = {11},
number = {1},
pages = {11--15},
doi = {10.11648/j.ijpc.20251101.12}
}
EUVIMED